We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics Signs Global and Exclusive in-Licensing Agreement with Galapagos

News   Mar 18, 2016

 
ThromboGenics Signs Global and Exclusive in-Licensing Agreement with Galapagos
 
 
 

RELATED ARTICLES

Liquid Biopsy Predicts Lymphoma Therapy Success Within Days

News

Being able to identify people who are responding well to therapy may spare them from unnecessary additional treatments.

READ MORE

Circulating Tumor Cell Clusters Identified in Head and Neck Cancer Patients

News

Australian study demonstrates the importance of detecting circulating tumor cell clusters using microfluidic technology.

READ MORE

Blood Test Could Identify Women at Risk for Gestational Diabetes

News

Early screening could allow for lifestyle changes before gestational diabetes develops.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE